Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24982782 | 0.88 | CA12 (0.39) | FAAHTSHRCAPN1KMT2AMEN1 | |
| SCHEMBL26364039 | 0.86 | SIGMAR1 (0.41) | TSHRRECQLKMT2AALDH1A1MEN1 | |
| SCHEMBL34468353 | 0.86 | FAAH (0.40) | FAAHTSHRMCL1HPGDCAPN1 | |
| SCHEMBL24918920 | 0.86 | MEN1 (0.42) | TSHRRECQLKMT2AALDH1A1MEN1 | |
| SCHEMBL24918878 | 0.86 | MEN1 (0.42) | TSHRRECQLKMT2AALDH1A1MEN1 | |
| SCHEMBL22959796 | 0.84 | SIGMAR1 (0.42) | TSHRRECQLKMT2AALDH1A1MEN1 | |
| SCHEMBL24918884 | 0.83 | SMN1; SMN2 (0.39) | TSHRHPGDKMT2AALDH1A1MEN1 | |
| SCHEMBL24193584 | 0.83 | TSHR (0.43) | FAAHTSHRHPGDRECQLKMT2A | |
| SCHEMBL15434480 | 0.81 | KDM4E (0.36) | FAAHTSHRMCL1HPGDALDH1A1 | |
| SCHEMBL15082725 | 0.81 | FAAH (0.45) | FAAHTSHRMCL1HPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230028880-A1 | CD38-BINDING AGENTS AND USES THEREOF | KLEO PHARMACEUTICALS, INC. | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230028880-A1 | CD38-BINDING AGENTS AND USES THEREOF | CD38, CD47, CD2 | FAAH 3364/4885TSHR 3454/4885MCL1 43/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.